ANALYSIS: Medtech firms raise over $750m in Q4 2012 amidst continued economic challenges
This article was originally published in Clinica
Some $756 million was invested in emerging medtech companies in the final quarter of 2012, according to Clinica's VC financing tracker, although deal volume continued to be depressed by concerns about the sector's vulnerability to the imminent US device sales tax and macroeconomic challenges in Europe.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.